SCHEMBL6537672

SCHEMBL6537672

Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1Oc1cccnc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.42
HSD17B10 Q99714 1/20 0.42
HTR2C P28335 6/20 0.42
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
KDR P35968 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
TYK2 P29597 1/20 0.40
PABPC1 P11940 1/20 0.40
EIF4H Q15056 1/20 0.40
HTR2B P41595 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538202 0.92 RAB9A (0.42) HTTHSD17B10HTR2CMAPTTP53
SCHEMBL6537627 0.87 PTGS2 (0.43) HTTHSD17B10MAPTSMN1; SMN2LMNA
SCHEMBL6537934 0.86 HTT (0.38) HTTHSD17B10MAPTTP53SMN1; SMN2
SCHEMBL6538353 0.85 MAPT (0.41) HTTHSD17B10MAPTTP53SMN1; SMN2
SCHEMBL6538054 0.84 TYK2 (0.44) HTTMAPTTP53SMN1; SMN2LMNA
SCHEMBL6537592 0.84 KMT2A (0.44) HTTMAPTSMN1; SMN2LMNATSHR
SCHEMBL6538368 0.83 P2RY14 (0.41) HTTHSD17B10HTR2CMAPTTP53
SCHEMBL6538040 0.82 MAPK10 (0.44) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL6536777 0.81 GAA (0.43) HTTMAPTSMN1; SMN2LMNAJAK2
SCHEMBL6537706 0.81 TYK2 (0.41) HTTMAPTTP53SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed